TD-1607

DRUG2 trials

Sponsors

Theravance Biopharma

Conditions

Bacterial InfectionsInfectionsSerious Infections Due to Known or Suspected Gram-positive Pathogens

Phase 1

TD-1607 SAD Study in Healthy Subjects

CompletedNCT01791049

Theravance BiopharmaSerious Infections Due to Known or Suspected Gram-positive Pathogens

Start: 2013-04-30End: 2013-10-31Updated: 2021-01-19

TD-1607 MAD Study in Healthy Subjects

CompletedNCT01949103

Theravance BiopharmaBacterial Infections, Infections

Start: 2013-10-31End: 2014-07-31Updated: 2021-01-19